Cefivir-T 1.125gm Injection
Marketer
Viribus Healthcare
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Cefivir-T 1.125gm Injection
Tricef-T 1.125g injection is a synergistic drug formulation indicated for treating diverse bacterial infections. Its mechanism combats microbial proliferation, thereby curbing infection spread. Administration of Tricef-T 1.125g injection necessitates a healthcare provider's oversight. Strict adherence to the prescribed dosage schedule is crucial; complete the full course of treatment regardless of symptom improvement. Premature cessation may compromise therapeutic efficacy. Potential adverse effects include, but aren't limited to, nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects warrant immediate physician consultation. Seek urgent medical attention for any allergic response (e.g., skin rash, pruritus, edema, dyspnea). Disclose all current medications to your physician before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from operating vehicles if experiencing somnolence or vertigo. Adequate rest, balanced nutrition, and sufficient hydration promote optimal recovery. Your doctor may order laboratory tests to monitor the drug's impact.
Uses of Cefivir-T 1.125gm Injection
Infections caused by bacteria
Major Benefits of Cefivir-T 1.125gm Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Cefivir-T 1.125gm Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cefivir-T 1.125gm Injection:
Administering this medication will be handled by your physician or their qualified nurse; self-medication is strongly discouraged.
How Cefivir-T 1.125gm Injection works:
Ceftriaxone and Tazobactum, the components of the injectable drug Cefivir-T 1.125gm, act synergistically to combat bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, thereby hindering bacterial growth. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Cefivir-T 1.125gm Injection and alcohol.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Cefivir-T 1.125gm Injection is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
The administration of Cefivir-T 1.125gm Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Cefivir-T 1.125gm Injection may induce drowsiness, visual disturbances, or dizziness. Driving is inadvisable if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Cefivir-T 1.125gm Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The use of Cefivir-T 1.125gm Injection requires careful consideration in individuals with significant hepatic impairment. A modified dosage of Cefivir-T 1.125gm Injection might be necessary. Medical advice is recommended. Dosage alteration for Cefivir-T 1.125gm Injection is not advised for those experiencing mild or moderately compromised liver function.
What if you forget to take Cefivir-T 1.125gm Injection :
Omitting a scheduled dose of Cefivir-T 1.125gm Injection requires immediate physician consultation.
Facts to Know About Cefivir-T 1.125gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently